+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Proteins Market - Global Forecast 2025-2030- Product Image
Recombinant Proteins Market - Global Forecast 2025-2030- Product Image
Sale

Recombinant Proteins Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5592125
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in the life sciences and biomanufacturing sectors are navigating a rapidly transforming landscape, with recombinant protein technology central to advancements in therapeutics, diagnostics, and vaccine development. Staying ahead requires clear understanding of emerging trends, regulatory shifts, and new supply chain dynamics poised to reshape the global competitive environment.

Market Snapshot: Recombinant Proteins Market Overview

The Recombinant Proteins Market grew from USD 5.80 billion in 2024 to USD 6.65 billion in 2025. It is expected to continue growing at a CAGR of 14.48%, reaching USD 13.06 billion by 2030. This sustained expansion reflects strong demand in drug development, tailored biologics, and in vitro diagnostics, supported by accelerating technology adoption and adaptive regulatory initiatives. The landscape is marked by both established players expanding their specialized offerings and a new wave of innovators leveraging flexible production technologies.

Scope & Segmentation

  • Application Areas: Diagnostics, research and development, therapeutics, and vaccines—spanning uses from basic laboratory investigation to clinical implementation and public health.
  • Product Types: Cytokines, enzymes, growth factors, and hormones tailored for pharmaceutical and diagnostic uses across varied industries.
  • Expression Systems: Bacterial, mammalian, plant, insect, and yeast platforms—including key hosts such as E. coli, CHO cells, and Pichia pastoris.
  • End Users: Academic and research institutes, contract research organizations, diagnostic laboratories, multinational pharmaceutical companies, and small to mid-sized biotech firms.
  • Form Factors: Liquid and lyophilized presentations designed for flexibility in storage and application needs.
  • Sales Channels: Direct sales and established distribution partners for broad market reach.
  • Regions: Americas, Europe, Middle East and Africa, Asia-Pacific, addressing distinct regulatory requirements and manufacturing strengths.

Key Takeaways for Decision-Makers

  • Recombinant protein technology is facilitating advanced therapeutic and diagnostic innovation, helping organizations address a wide spectrum of unmet clinical needs.
  • Global adoption of next-generation expression systems—including synthetic biology and cell-free platforms—offers producers greater flexibility and efficiency optimization.
  • Regulatory harmonization and evolving quality standards are encouraging agile product development and faster time-to-market across high-growth and established markets.
  • Investment in bioprocess digitalization, from real-time data analytics to artificial intelligence-driven controls, enables improved process scalability and batch reliability.
  • Collaborative models—between academia, industry, and contract manufacturing—are accelerating technology transfer and strengthening commercialization strategies.

Tariff Impact on Supply Chain and Procurement

Recent U.S. trade tariffs implemented in 2025 are reshaping procurement strategies for recombinant proteins by increasing core material and equipment costs. In response, firms are diversifying supplier networks with strategic regional partnerships across Asia-Pacific and Europe to ensure resilient material flows and offset cost volatility. Internalizing manufacturing steps and optimizing formulations are helping organizations adapt to these dynamic trade challenges while maintaining product quality and delivery timelines.

Methodology & Data Sources

This research leverages a multi-faceted approach, combining extensive secondary analysis of scientific literature, regulatory documents, and market databases with in-depth primary interviews from a cross-section of executives and domain experts. Triangulation of qualitative and quantitative insights ensures robust and reliable forecasts, with validation workshops conducted to confirm data integrity and segmentation logic.

Why This Report Matters

  • Provides senior leaders with actionable insights into market segmentation, emerging technologies, and evolving regional trends, supporting confident and informed strategic planning.
  • Highlights operational and regulatory pressures, equipping stakeholders to anticipate supply chain risks and proactively address tariff implications and regulatory realignments.

Conclusion

The recombinant proteins market is advancing through innovation, regulatory modernization, and new supply chain strategies. Organizations ready to integrate digital technologies, diversify sourcing, and forge collaborative ecosystems are well positioned to sustain growth and address future healthcare demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of modular antibody-drug conjugates using recombinant protein scaffolds for targeted oncology therapies
5.2. Integration of plant-based transient expression systems to accelerate large-scale vaccine antigen production
5.3. Development of engineered protein subunit vaccines using novel adjuvant-binding recombinant antigens
5.4. Application of CRISPR/Cas9 genome editing for optimized recombinant enzyme expression in microbial hosts
5.5. Adoption of continuous perfusion bioreactors for high-yield monoclonal antibody manufacturing processes
5.6. Advances in synthetic biology enabling customizable recombinant protein glycoengineering for improved efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Recombinant Proteins Market, by Application
8.1. Introduction
8.2. Diagnostics
8.2.1. Imaging Agents
8.2.2. In Vitro Diagnostics
8.3. Research And Development
8.3.1. Basic Research
8.3.2. Drug Discovery
8.3.3. Process Development
8.4. Therapeutics
8.4.1. Autoimmune
8.4.2. Cardiovascular
8.4.3. Oncology
8.5. Vaccines
8.5.1. Prophylactic
8.5.2. Therapeutic
9. Recombinant Proteins Market, by Product Type
9.1. Introduction
9.2. Cytokines
9.3. Enzymes
9.4. Growth Factors
9.5. Hormones
10. Recombinant Proteins Market, by Expression System
10.1. Introduction
10.2. Bacterial
10.2.1. E Coli
10.3. Insect
10.3.1. Baculovirus Expression
10.4. Mammalian
10.4.1. CHO Cells
10.4.2. HEK Cells
10.5. Plant
10.5.1. Transgenic Plants
10.6. Yeast
10.6.1. Pichia Pastoris
10.6.2. Saccharomyces Cerevisiae
11. Recombinant Proteins Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical And Biotech Companies
11.5.1. Large Pharma
11.5.2. Small And Medium Biotech
12. Recombinant Proteins Market, by Form
12.1. Introduction
12.2. Liquid Form
12.3. Lyophilized Form
13. Recombinant Proteins Market, by Sales Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distribution Partners
14. Americas Recombinant Proteins Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Recombinant Proteins Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Recombinant Proteins Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Danaher Corporation
17.3.4. Sartorius AG
17.3.5. Lonza Group Ltd.
17.3.6. F. Hoffmann-La Roche Ltd.
17.3.7. Boehringer Ingelheim International GmbH
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. Bio-Techne Corporation
17.3.10. Abcam plc
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. RECOMBINANT PROTEINS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RECOMBINANT PROTEINS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RECOMBINANT PROTEINS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. RECOMBINANT PROTEINS MARKET: RESEARCHAI
FIGURE 28. RECOMBINANT PROTEINS MARKET: RESEARCHSTATISTICS
FIGURE 29. RECOMBINANT PROTEINS MARKET: RESEARCHCONTACTS
FIGURE 30. RECOMBINANT PROTEINS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RECOMBINANT PROTEINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY E COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY E COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACULOVIRUS EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACULOVIRUS EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HEK CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HEK CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY TRANSGENIC PLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY TRANSGENIC PLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LYOPHILIZED FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LYOPHILIZED FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 189. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 194. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 195. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 196. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 197. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 198. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 199. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 202. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 203. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 204. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 205. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 206. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 207. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 208. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 209. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 210. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 211. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 212. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 213. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 216. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 217. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 218. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 219. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 226. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 227. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 234. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 235. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 236. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 237. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 238. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 239. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 240. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 241. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 242. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 243. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 244. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 245. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 250. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 251. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Recombinant Proteins market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Sartorius AG
  • Lonza Group Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Boehringer Ingelheim International GmbH
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Abcam plc

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.65 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.06 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Recombinant Protein Industrial Reagents Market - Global Forecast 2025-2030 - Product Image

Recombinant Protein Industrial Reagents Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Recombinant Protein Biological Research Reagents Market - Global Forecast 2025-2030 - Product Image

Recombinant Protein Biological Research Reagents Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Recombinant Proteins Market Size, Share & Trends Analysis Report by Product (Cytokines & Growth Factors, Antibodies), Application (Therapeutics), End-use, Host Cell (Mammalian), Region, and Segment Forecasts, 2025-2030 - Product Image

Recombinant Proteins Market Size, Share & Trends Analysis Report by Product (Cytokines & Growth Factors, Antibodies), Application (Therapeutics), End-use, Host Cell (Mammalian), Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Recombinant Proteins Manufacturing Services - Global Strategic Business Report - Product Image

Recombinant Proteins Manufacturing Services - Global Strategic Business Report

  • Report
  • 175 Pages
  • Global
From
Custom Recombinant Proteins - Global Strategic Business Report - Product Image

Custom Recombinant Proteins - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.